[Kinase inhibitors and their resistance]

Area of Science:

• Oncology
• Molecular Biology
• Pharmacology

Background:

• Kinase cascades are integral to tumorigenesis, regulating cell transformation, differentiation, cell-cycle progression, and motility.
• Molecularly targeted drugs, particularly kinase inhibitors, are crucial in treating cancers with specific oncogenic driver mutations.

Purpose of the Study:

• To review solid tumor-related kinase signals and their inhibitors used in clinical settings.
• To summarize the mechanisms of resistance to these kinase inhibitors.

Main Methods:

• Literature review of kinase signaling pathways in solid tumors.
• Analysis of clinical applications of kinase inhibitors.
• Compilation of data on resistance mechanisms.

Main Results:

• Kinase inhibitors targeting receptor tyrosine kinases and serine/threonine kinases have shown clinical success.
• Specific oncogenic driver signals in malignancies are amenable to targeted inhibition.
• Understanding resistance mechanisms is key to improving long-term treatment efficacy.

Conclusions:

• Targeted kinase inhibitors represent a significant advancement in cancer therapy, especially for tumors with addiction to specific signaling pathways.
• Further research into overcoming resistance mechanisms is essential for optimizing patient outcomes in solid tumor treatment.